{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:32:56Z","timestamp":1790681576473,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009663","name":"University Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fecal transplantation (FT) is a promising treatment for recurrent Clostridium difficile infection (CDI), but its true effectiveness remains unknown. We compared 14 days of oral vancomycin followed by a single FT by enema with oral vancomycin taper (standard of care) in adult patients experiencing acute recurrence of CDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a phase 2\/3, single-center, open-label trial, participants from Ontario, Canada, experiencing recurrence of CDI were randomly assigned in a 1:1 ratio to 14 days of oral vancomycin treatment followed by a single 500-mL FT by enema, or a 6-week taper of oral vancomycin. Patients with significant immunocompromise, history of fulminant CDI, or irreversible bleeding disorders were excluded. The primary endpoint was CDI recurrence within 120 days. Microbiota analysis was performed on fecal filtrate from donors and stool samples from FT recipients, as available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study was terminated at the interim analysis after randomizing 30 patients. Nine of 16 (56.2%) patients who received FT and 5 of 12 (41.7%) in the vancomycin taper group experienced recurrence of CDI, corresponding with symptom resolution in 43.8% and 58.3%, respectively. Fecal microbiota analysis of 3 successful FT recipients demonstrated increased diversity. A futility analysis did not support continuing the study. Adverse events were similar in both groups and uncommon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients experiencing an acute episode of recurrent CDI, a single FT by enema was not significantly different from oral vancomycin taper in reducing recurrent CDI. Further research is needed to explore optimal donor selection, FT preparation, route, timing, and number of administrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>NCT01226992.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciw731","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:06:07Z","timestamp":1477958767000},"page":"265-271","source":"Crossref","is-referenced-by-count":164,"title":["Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial"],"prefix":"10.1093","volume":"64","author":[{"given":"Susy S","family":"Hota","sequence":"first","affiliation":[{"name":"Department of Infection Prevention and Control, University Health Network, Toronto"},{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Medicine, University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Sales","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Medicine, Markham-Stouffville Hospital, Markham"},{"name":"Department of Medicine, University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tomlinson","sequence":"first","affiliation":[{"name":"Department of Medicine, University Health Network"},{"name":"Institute of Health Policy, Management and Evaluation and Dalla Lana School of Public Health, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Salpeter","sequence":"first","affiliation":[{"name":"Department of Infection Prevention and Control, University Health Network, Toronto"},{"name":"Department of Anaesthesia, University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Microbiology, University Health Network\/Sinai Health System"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Coburn","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Medicine, University Health Network"},{"name":"Toronto General Research Institute, University Health Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Guttman","sequence":"first","affiliation":[{"name":"Department of Cell and Systems Biology, University of Toronto"},{"name":"Centre for the Analysis of Genome Evolution and Function, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E","family":"Low","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Microbiology, University Health Network\/Sinai Health System"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Poutanen","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto"},{"name":"Department of Microbiology, University Health Network\/Sinai Health System"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"2020031810473859200_CIT0001","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMx060024","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile\u2013associated diarrhea with high morbidity and mortality","volume":"354","author":"Loo","year":"2006","journal-title":"N Engl J Med"},{"key":"2020031810473859200_CIT0002","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020031810473859200_CIT0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020031810473859200_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20(","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020031810473859200_CIT0005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2020031810473859200_CIT0006","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1365-2036.2012.05033.x","article-title":"Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease","volume":"35","author":"Guo","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2020031810473859200_CIT0007","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","article-title":"Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection","volume":"53","author":"Gough","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020031810473859200_CIT0008","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCG.0000000000000046","article-title":"Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review","volume":"48","author":"Cammarota","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"2020031810473859200_CIT0009","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M14-2693","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: a systematic review","volume":"162","author":"Drekonja","year":"2015","journal-title":"Ann Intern Med"},{"key":"2020031810473859200_CIT0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"2020031810473859200_CIT0011","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2020031810473859200_CIT0012","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020031810473859200_CIT0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"key":"2020031810473859200_CIT0014","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann Intern Med"},{"key":"2020031810473859200_CIT0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2014.08.007","article-title":"Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges","volume":"34","author":"Kassam","year":"2014","journal-title":"Clin Lab Med"},{"key":"2020031810473859200_CIT0016","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020031810473859200_CIT0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1155\/2014\/346590","article-title":"Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy","volume":"28","author":"Moayyedi","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2020031810473859200_CIT0018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1155\/2012\/213828","article-title":"A Canadian working group report on fecal microbial therapy: microbial ecosystems therapeutics","volume":"26","author":"Allen-Vercoe","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"2020031810473859200_CIT0019","volume-title":"Draft guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies","author":"US Food and Drug Administration"},{"key":"2020031810473859200_CIT0020","volume-title":"Guidance document: fecal microbiota therapy used in the treatment of Clostridium difficile infection not responsive to conventional therapies","author":"Health Canada"},{"key":"2020031810473859200_CIT0021","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","article-title":"Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian nosocomial infection surveillance program study","volume":"48","author":"Gravel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020031810473859200_CIT0022","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.mcg.0000128988.13808.dc","article-title":"Bacteriotherapy using fecal flora: toying with human motions","volume":"38","author":"Borody","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"2020031810473859200_CIT0023","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020031810473859200_CIT0024","first-page":"3284","article-title":"Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscopy","volume":"95","author":"Persky","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2020031810473859200_CIT0025","unstructured":"Prayitno\n              N\n            \n            \n              Akhavan\n              P\n            \n            \n              Khan\n              M\n            \n            et al.\n          . Determination of the optimal storage duration and conditions for fecal transplantation (FTX) samples. In: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 17\u201320 September 2011. Abstract K-203."},{"key":"2020031810473859200_CIT0026","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ismej.2012.8","article-title":"Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms","volume":"6","author":"Caporaso","year":"2012","journal-title":"ISME J"},{"key":"2020031810473859200_CIT0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"2020031810473859200_CIT0028","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2020031810473859200_CIT0029","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/sim.2204","article-title":"Bayesian predictive approach to interim monitoring in clinical trials","volume":"25","author":"Dmitrienko","year":"2006","journal-title":"Stat Med"},{"key":"2020031810473859200_CIT0030","volume-title":"R: a language and environment for statistical computing","author":"R Core Team"},{"key":"2020031810473859200_CIT0031","doi-asserted-by":"crossref","first-page":"e76269","DOI":"10.1371\/journal.pone.0076269","article-title":"Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole","volume":"8","author":"Abujamel","year":"2013","journal-title":"PLoS One"},{"key":"2020031810473859200_CIT0032","first-page":"867","article-title":"Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis","volume":"80","author":"Tedesco","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"2020031810473859200_CIT0033","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/MCG.0000000000000447","article-title":"A high rate of alternative diagnosis in patients referred for presumed Clostridium difficile infection","volume":"50","author":"Jackson","year":"2015","journal-title":"J Clin Gastroenterol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/3\/265\/32926780\/ciw731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/3\/265\/32926780\/ciw731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T10:48:17Z","timestamp":1584528497000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/3\/265\/2452658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,11,9]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw731","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2016,11,9]]}}}